Cell-Derived Microparticles

• 

  Subject Areas on Research

  • Assessing the immune status of critically ill trauma patients by flow cytometry. 
  • CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L. 
  • Dive, food, and exercise effects on blood microparticles in Steller sea lions (Eumetopias jubatus): exploring a biomarker for decompression sickness. 
  • Dysregulation of hemostasis by cancer. 
  • Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects. 
  • Effects of progesterone and estradiol sex hormones on the release of microparticles by RAW 264.7 macrophages stimulated by Poly(I:C). 
  • Endocytosis of Red Blood Cell Microparticles by Pulmonary Endothelial Cells is Mediated By Rab5. 
  • Erythrocyte-Derived Microparticles Activate Pulmonary Endothelial Cells in a Murine Model of Transfusion. 
  • HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. 
  • Induction of apoptosis in circulating angiogenic cells by microparticles. 
  • Lack of the P2X7 receptor protects against AMD-like defects and microparticle accumulation in a chronic oxidative stress-induced mouse model of AMD. 
  • Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. 
  • Mast cell-derived particles deliver peripheral signals to remote lymph nodes. 
  • Microparticles as a source of extracellular DNA. 
  • Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. 
  • Microparticles as autoadjuvants in the pathogenesis of SLE. 
  • Microparticles as autoantigens in systemic lupus erythematosus. 
  • Microparticles as autoantigens: making immune complexes big. 
  • Microparticles as biomarkers in autoimmunity: from dust bin to center stage. 
  • Microparticles as mediators and biomarkers of rheumatic disease. 
  • Microparticles from aged packed red blood cell units stimulate pulmonary microthrombus formation via P-selectin. 
  • Microparticles from stored red blood cells promote a hypercoagulable state in a murine model of transfusion. 
  • Microparticles in cardiovascular disease pathophysiology and outcomes. 
  • Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes. 
  • Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations. 
  • Muscle-Derived Extracellular Vesicles Influence Motor Neuron Regeneration Accuracy. 
  • Offense and defense: microbial membrane vesicles play both ways. 
  • PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. 
  • PRCD is essential for high-fidelity photoreceptor disc formation. 
  • Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles. 
  • Photoreceptor Discs: Built Like Ectosomes. 
  • Photoreceptor discs form through peripherin-dependent suppression of ciliary ectosome release. 
  • Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch. 
  • Platelet microparticles: making blood a bad humor. 
  • Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. 
  • Randomized study of washing 40- to 42-day-stored red blood cells. 
  • Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways. 
  • Targeted anti-IL-1β platelet microparticles for cardiac detoxing and repair. 
  • The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. 
  • The effect of pathogen inactivation on cryoprecipitate: a functional and quantitative evaluation. 
  • The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers. 
  • The expression of HMGB1 on microparticles from Jurkat and HL-60 cells undergoing apoptosis in vitro. 
  • The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. 
  • The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment. 
  • The properties of microparticles from RAW 264.7 macrophage cells undergoing in vitro activation or apoptosis. 
  • The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. 
  • The release of microparticles and mitochondria from RAW 264.7 murine macrophage cells undergoing necroptotic cell death in vitro. 
  • The release of microparticles by Jurkat leukemia T cells treated with staurosporine and related kinase inhibitors to induce apoptosis. 
  • The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells. 
  • The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. 
  • The role of microparticles in the generation of immune complexes in murine lupus. 
  • The role of microparticles in the pathogenesis of rheumatic diseases. 
  • The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. 
  • Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology